Virtus LifeSci Biotech Clinical Trials ETF
19 hedge funds and large institutions have $42.1M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
9
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
UCFA
1
United Capital Financial Advisors
Irving,
Texas
|
$4.87M |
2 |
NCM
2
Niemann Capital Management
Stateline,
Nevada
|
$16.6M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$0 |